Cross Country Healthcare (NASDAQ:CCRN – Get Free Report)‘s stock had its “neutral” rating reiterated by equities research analysts at Wedbush in a research note issued on Thursday,Benzinga reports. They currently have a $13.25 price target on the business services provider’s stock, down from their previous price target of $15.00. Wedbush’s target price would suggest a potential upside of 1.33% from the company’s current price.
Several other research analysts also recently commented on the company. Benchmark raised Cross Country Healthcare from a “hold” rating to a “buy” rating and set a $14.00 target price on the stock in a report on Thursday, March 5th. Cross Research set a $14.00 price objective on Cross Country Healthcare in a research report on Thursday, March 5th. Weiss Ratings reissued a “sell (e+)” rating on shares of Cross Country Healthcare in a research note on Friday, March 27th. Finally, Zacks Research upgraded Cross Country Healthcare from a “strong sell” rating to a “hold” rating in a report on Monday, January 19th. Three equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $12.31.
Check Out Our Latest Analysis on CCRN
Cross Country Healthcare Stock Performance
Cross Country Healthcare (NASDAQ:CCRN – Get Free Report) last announced its quarterly earnings results on Wednesday, March 4th. The business services provider reported ($0.06) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.03 by ($0.09). The firm had revenue of $236.76 million for the quarter, compared to the consensus estimate of $254.30 million. Cross Country Healthcare had a negative net margin of 9.00% and a positive return on equity of 0.13%. Cross Country Healthcare has set its Q1 2026 guidance at -0.060–0.040 EPS. As a group, sell-side analysts predict that Cross Country Healthcare will post 0.09 EPS for the current year.
Institutional Inflows and Outflows
Several institutional investors have recently bought and sold shares of CCRN. Quinn Opportunity Partners LLC bought a new stake in shares of Cross Country Healthcare during the fourth quarter worth approximately $8,470,000. Boston Partners bought a new stake in shares of Cross Country Healthcare during the 4th quarter valued at $6,414,000. Dana Investment Advisors Inc. lifted its stake in shares of Cross Country Healthcare by 71.2% in the 4th quarter. Dana Investment Advisors Inc. now owns 1,008,525 shares of the business services provider’s stock valued at $8,169,000 after purchasing an additional 419,429 shares during the period. Goldman Sachs Group Inc. boosted its position in shares of Cross Country Healthcare by 56.9% in the 1st quarter. Goldman Sachs Group Inc. now owns 1,095,178 shares of the business services provider’s stock worth $16,307,000 after purchasing an additional 397,216 shares during the last quarter. Finally, Royce & Associates LP acquired a new stake in shares of Cross Country Healthcare during the fourth quarter worth $3,208,000. Institutional investors own 96.03% of the company’s stock.
Cross Country Healthcare Company Profile
Cross Country Healthcare, Inc, headquartered in Boca Raton, Florida, is a leading provider of healthcare workforce solutions in the United States. The company specializes in the recruitment, placement and management of nursing and allied health professionals on both a travel and permanent basis. Through its integrated platform, Cross Country Healthcare serves hospitals, health systems, and long-term care facilities by matching qualified clinical talent with patient care needs across diverse care settings.
The company’s core service offerings include travel nurse and allied health staffing, per diem staffing, permanent placement services, and managed services programs.
Featured Articles
Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
